Azacytidine treatment led to increased expression of miR‐369‐5p and miR‐369‐3p in GC cells, suggesting that AZA might also lead to decreased expression of c‐Jun and AKT1 in GC cells. This evidence concerns the gene JUN and gastric cancer.